Germline pathogenic variants in BRCA1 predispose carriers to significantly elevated risks of breast and ovarian cancers [46], but the relationship between BRCA1 and CRC susceptibility is less clear [22]. This evidence concerns the gene BRCA1 and ovarian carcinoma.